COMBINATORIAL EFFECT OF LEPTIN, TUMOR NECROSIS FACTOR-ΑLPHA, AND VITAMIN D IN PROGRESSION OF TYPE 2 DIABETES IN KASHMIRI POPULATION
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i10.28097Keywords:
Type 2 Diabetes Mellitus, Leptin, Nil, Vitamin D, Enzyme-linked immunosorbent assayAbstract
Objectives: Type 2 diabetes mellitus (T2DM) is a metabolic disorder usually characterized by hyperglycemia. Adipose tissue secretes bioactive substances known as adipocytokines including leptin, tumor necrosis factor-alpha (TNF-α), and adiponectin. These are considered as a bridge connecting obesity and insulin resistance. There is considerable epidemiological evidence to suggest a role of Vitamin D deficiency in the etiology of T2DM. This study was performed to evaluate and compare serum Vitamin D and adipocytokine levels in T2DM patients and healthy controls of Jammu and Kashmir region of India.
Methods: A total of 200 T2DM patients and normal 200 healthy controls were considered for the study. Enzyme-linked immunosorbent assay was used to measure serum leptin and TNF-α levels. The Vitamin D levels were measured by chemiluminescent microparticle immunoassay method. Biochemical parameters were measured by the enzymatic method.
Results: Our results concluded that basic metabolic parameters, TNF-α and leptin levels were significantly higher in cases than controls. The serum Vitamin D levels were found significantly lower among T2DM patients. No correlation of Vitamin D with leptin was observed in cases and controls. However, a positive correlation between leptin and TNF-α was noted in T2DM subjects as well as in controls with statistical significance being higher in females (r=0.500; p=0.001) as compared to males (r=0.298; p=0.036) in T2DM subjects as well as in controls (r=0.659; p=0.001; r=0.621; p=001).
Conclusion: These results concluded that lowering of Vitamin D levels and upregulation of leptin and TNF-α altogether play an important role in the development of T2DM, and from correlation analysis, it could be predicted that leptin and TNF-α act in a synergistic manner toward the development of T2DM.
Downloads
References
Arafat M, Salam A, Arafat O. The association of Type 2 diabetes with obesity and other factors in multinational community. Int J Pharm Pharm Sci 2014;9:257-60.
Dhodi JB, Mestry SN, Juvekar AR. Diabetic nephropathy-genesis, prevention and treatment. Int J Pharm Pharm Sci 2014;9:42-7.
Nedvidkova J, Smitka K, Kopsky V, Hainer V. Adiponectin, an adipocytederived protein. Physiol Res 2005;54:133-40.
Gwozdziewiczova S, Lichnovska R, Yahia RB, Chulp R, Hrebicek J. TNF-alpha in the development of insulin resistance and other disorders in metabolic syndrome. BioMed 2005;149:109-17.
Bastard JP, Maachi M, Lagethu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation and insulin resistance. Euro Cytokine Netw 2006;17:4-12.
Zou C, Shao J. Role of adipocytokines in obesity-associated insulin resistance. J Nutr Biochem 2008;19:277-86.
Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-jun NH(2)- terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of ser(307). J Biol Chem 2000;275:9047-54.
Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA. Tumor necrosis factor alpha and insulinresistance in obese Type 2 diabetic patients. Int J Obes Relat Metab Disord 2003;27:88-94.
Swaroop JJ, Rajarajeswari D, Naidu JN. Association of TNF-α with insulin resistance in Type 2 diabetes mellitus. Indian J Med Res 2012;135:127-30.
Kamahora S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997;389:374-7.
Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, et al. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothala-micarea. Neuron 1999;23:775-86.
Paz-Filho G, Mastronardi C, Wong ML, Licinio J. Leptin therapy, insulin sensitivity, and glucose homeostasis. Indian J Endocr Metab 2012;16:549-55.
Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004;80:1706-9.
Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-73.
Majeed I, Farooq R, Malik R, Majid S. Estimation of lipid peroxidation and lipid profile levels in Type II diabetes mellitus patients of Kashmir valley. Int J Adv Life Sci 2015;40:448-52.
Rashid T, Bhat SA, Wani MU, Majid S, Hassan I, Rashid S, et al. The lipid peroxidation and antioxidant status of Type 2 diabetic patients in Kashmir (India). Int J Diab Dev Coun 2015;4:476-81.
Malik R, Farooq R, Mehta P, Ishaq S, Din I, Shah P, Majid S. Association of vitamin D receptor gene polymorphism in patients with Type 2 diabetes in the Kashmir valley. Can J Diab 2017;16:30514-7.
Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxy vitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011;57:63-9.
Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum vitamin D concentrations in healthy women. J Inflam 2008;5:5-10.
Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am J Med 2010;123:335-41.
Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxy vitamin D and 1, 25-dihydroxy vitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9.
Bellia A, Garcovich CD, Adam M, Lombardo M, TesauroM, Donadel G, et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 2011; 8: 33-40.
Ganji V, Zhang X, Shaikh N, Tangpricha V. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001–2006. Am J Clin Nutr 2011;94:225-33.
Hyppoenen E, Berry D, Cortina-Borja M, Power C. 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: A cross sectional analysis in the 1958. PLoS One 2010;5:e10801.
Jorde R, Haug E, Figenschau Y, Hansen JB. Serum levels of vitamin D and haemostatic factors in healthy subjects: The Tromso study. Acta Haemat 2007;117:91-7.
Vilarrasa N, Vendrell J, Maravall J, Elio I, Solano E, San Jose P, et al. Is plasma vitamin D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 2010;38:235-42.
Rayees S, Mabalirajan U, Bhat WW, Rasool S, Rather RA, Panda L, et al. Therapeutic effects of R8, a semi-synthetic analogue of Vasicine, on murine model of allergic airway inflammation via STAT6 inhibition. Int Immunopharmacol 2015;26:246-56.
Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: A review of current trends. Oman Med J 2012;4:269-73.
Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of Type 2 diabetes mellitus. Diabetes Obes Metab 2008;10:185-97.
Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E, et al. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 1995;27:181-8.
Pittas A, Dawson-Hughes B. Vitamin D and diabetes. J Sterol Biochem Mol 2010;121:425-9.
Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 1996;45:822-4.
Maahs DM, Hamman RF, D’Agostino R Jr., Dolan LM, Imperatore G, Lawrence JM, et al. The association between adiponectin/leptin ratio and diabetes type: The search for Diabetes in youth study. J Pediatr 2009;155:133-5.
Wannamethee SG, Tchernova J, Whincup P. Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2007;191:418-26.
Welsh P, Murray HM, Buckley BM, de Craen AJ, Ford I, Jukema JW, et al. Leptin predicts diabetes but not cardiovascular disease: Results from a large prospective study in an elderly population. Diabetes Care 2009;32:308-10.
Sun Q, van Dam RM, Meigs JB, Franco OH, Mantzoros CS, Hu FB, et al. Leptin and soluble leptin receptor levels in plasma and risk of Type 2 diabetes in U.S. Women: A prospective study. Diabetes 2010;59:611-8.
Rayees S, Malik F, Bukhari SI, Singh G. Linking GATA-3 and interleukin-13: Implications in asthma. Inflamm Res 2014;4:255-65.
Rayees S, Kumar A, Rasool S, Kaiser P, Satti NK, Sangwan PL, et al. Ethanolic extract of Alternanthera sessilis (AS-1) inhibits IgE-mediated allergic response in RBL-2H3 cells. Immunol Invest 2013;6:470-80.
Rayees S, Johri RK, Singh G, Tikoo MK, Singh SS, Sharma SC, Rai PK, et al. Sitopaladi, a poly-herbal formulation inhibits IgE mediated allergic reactions. Spatula DD 2012;2:75-82.
Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and Type 2 diabetes. Trends Endocrin Metab 2000; 11: 212 7.
Bluher M, Kratzsch J, Paschke R. Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth harmone, and IGF-1 are not elevated in insulin-resistant obese individuals with impaired glucose tolerance. Diab Care 2001;24:328-34.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.